Immediate and Long-term Clinical Benefits of a Topical Treatment for Facial Lines and Wrinkles.
- 1 March 2009
- journal article
- Vol. 2 (3), 38-43
Abstract
To evaluate the efficacy and tolerance of a novel line treatment for periocular and perioral wrinkles. The line treatment was formulated with multiple growth factors, antioxidants, and a collagen-building peptide-ingredients that have been shown to increase collagen levels and provide long-term aesthetic benefits. To help provide immediate smoothing effects, hyaluronic acid filling spheres and a muscle contraction-inhibiting peptide were also included in the formulation. Three-month, single-center, open-label, clinical study with clinical assessments at Baseline, Minutes (within 15 minutes of initial application), Month 1, and Month 3. Subjects treated periocular and perioral wrinkles twice daily for three months with the line treatment. Thirty-seven females, 33 to 45 years of age, with mild-to-moderate, fine and coarse periocular and perioral wrinkles, were enrolled in the study. Investigator assessments of fine and coarse periocular and perioral wrinkles, digital photography, and tolerance assessments were conducted at all visits. Subject self-assessment questionnaires were conducted within 15 minutes of initial application and at Month 3. Investigator assessments of both periocular and perioral wrinkles showed statistically significant improvements over Baseline within minutes of initial application; these positive findings continued to improve through Months 1 and 3 (all P</=0.0003). No treatment-related adverse events were reported. The results from this study demonstrate that this uniquely formulated line treatment was well tolerated and provided both immediate and long-term improvements in the appearance of fine and coarse wrinkles.This publication has 20 references indexed in Scilit:
- The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure.2008
- Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation.2007
- [Clinical applications of hyaluronic acid].2006
- Topical Vitamin CDermatologic Surgery, 2005
- Activation of latent TGF-β by thrombospondin-1: mechanisms and physiologyCytokine & Growth Factor Reviews, 2000
- Insights into MMP‐TIMP InteractionsAnnals of the New York Academy of Sciences, 1999
- Waglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor.1999
- Coenzyme Q10, a cutaneous antioxidant and energizerBioFactors, 1999
- Central Role of Ferrous/Ferric Iron in the Ultraviolet B Irradiation-mediated Signaling Pathway Leading to Increased Interstitial Collagenase (Matrix-degrading Metalloprotease (MMP)-1) and Stromelysin-1 (MMP-3) mRNA Levels in Cultured Human Dermal FibroblastsJournal of Biological Chemistry, 1998
- Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblastsBiochemical Journal, 1987